CIK: 0001664974 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value ($000): $135,073 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EVLV | Evolv Technologies Holdings, Inc. | 10,601,281 | $63,608 | 47.1% | $5.61 | -15.7% | COM CL A | 30049H102 |
| RXRX | Recursion Pharmaceuticals, Inc. | 5,941,120 | $44,380 | 32.9% | $18.82 | -62.8% | CL A | 75629V104 |
| — | Rocket Lab USA, Inc. | 2,929,350 | $17,576 | 13.0% | $4.04 | — | COM | 773122106 |
| — | Embark Technology, Inc. | 3,186,007 | $9,112 | 6.7% | $7.43 | — | COM NEW | 29079J202 |
| — | Mind Medicine (MindMed) Inc. | 100,350 | $358 | 0.3% | $3.17 | — | COM NEW | 60255C885 |
| ROIV | Roivant Sciences Ltd. | 3,875 | $39 | 0.0% | $5.56 | +60.8% | SHS | G76279101 |